Skip to main content
DBVT
NASDAQ Life Sciences

Bpifrance Participations Reduces Stake to 5.2% After Exercising Warrants and Selling Shares

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$16.99
Mkt Cap
$767.956M
52W Low
$3.15
52W High
$26.185
52W Position info
439% above low
Off High info
35% below high
Rel. Volume info
1.3× avg
Market data snapshot near publication time

DBVT has more than doubled off its 52-week low of $3.15.

Summary

Bpifrance Participations, a significant institutional investor, reduced its beneficial ownership in DBV Technologies S.A. to 5.2% after exercising warrants and subsequently selling approximately $11.5 million worth of shares in open market transactions.


Key Events · Ownership and Investor Activity · DBVT

  • Significant Share Sales

    Bpifrance Participations sold approximately 3.1 million Ordinary Shares in open market transactions from December 19, 2025, to January 2, 2026.

  • Total Transaction Value

    The aggregate value of the shares sold by Bpifrance Participations was approximately $11.5 million.

  • Warrant Exercise

    Prior to the sales, Bpifrance Participations exercised warrants to acquire 6,556,781 Ordinary Shares for approximately EUR 5.97 million.

  • Reduced Ownership Stake

    Following these transactions, Bpifrance Participations' beneficial ownership in DBV Technologies S.A. decreased to 5.2% of the outstanding Ordinary Shares.


Analysis · DBVT · Life Sciences

This Schedule 13D/A filing indicates that Bpifrance Participations, a major institutional shareholder, has decreased its stake in DBV Technologies S.A. The entity first exercised warrants to acquire 6.56 million shares and then proceeded to sell over 3.1 million shares in open market transactions between December 19, 2025, and January 2, 2026. These sales, totaling approximately $11.5 million, represent a notable reduction in the investor's exposure to the company, bringing their beneficial ownership down to 5.2%. While the warrant exercise increased their share count, the subsequent sales suggest a strategic rebalancing or reduction of their position.

At the time of this filing, DBVT was trading at $16.99 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $768M. The 52-week trading range was $3.15 to $26.19. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

DBVT - Latest Insights

DBVT
Jul 27, 2026, 7:46 AM EDT
Filing Type: S-3ASR
Importance Score:
7
Price at Filing: $13.77
Real-time Price: $13.78 info
Change: +$0.0100 (+0.07%) info
Market Cap: $800.711M info
DBVT
Jul 16, 2026, 5:02 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $14.86
Real-time Price: $13.78 info
Change: -$1.08 (-7%) info
Market Cap: $800.711M info
DBVT
Jul 16, 2026, 4:08 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $14.86
Real-time Price: $13.78 info
Change: -$1.08 (-7%) info
Market Cap: $800.711M info
DBVT
Jun 29, 2026, 4:28 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $16.00
Real-time Price: $13.78 info
Change: -$2.22 (-14%) info
Market Cap: $800.711M info
DBVT
Jun 05, 2026, 4:01 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $16.59
Real-time Price: $13.78 info
Change: -$2.81 (-17%) info
Market Cap: $800.711M info